Ferozsons Laboratories Limited reported a strong performance for the first quarter ended 30 September 2026
Filed as: Financial Results for the Quarter Ended 30-09-2026
Summary
Ferozsons Laboratories Limited reported a strong performance for the first quarter ended 30 September 2026, with net profit increasing to Rs 219.64 million and revenue reaching Rs 4.77 billion.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | PKR 4.77 billion | PKR 3.88 billion | +22.9% |
| Net Profit | PKR 219.64 million | PKR 182.42 million | +20.4% |
| Earnings Per Share (EPS) | PKR 5.05 | PKR 4.20 | +20.2% |
| Gross Profit | PKR 1.95 billion | PKR 1.58 billion | +23.4% |
| Profit from Operations | PKR 442.26 million | PKR 377.30 million | +17.2% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue increased by 22.89% to Rs 4.77 billion compared to Rs 3.88 billion in the prior period.
- Net profit rose by 20.41% to Rs 219.64 million from Rs 182.42 million in the previous year.
- Earnings per share improved to Rs 5.05 from Rs 4.20, reflecting a strong bottom-line performance.
Ferozsons Laboratories Limited (FEROZ) on Nafa
Last price Rs 364.02 · Pharmaceuticals · You can own FEROZ shares from your phone.
More FEROZ announcements
Source: Ferozsons Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.